ACIP Recommendations (by Date Published)
Consult the ACIP Recommendations page for a complete list of Morbidity and Mortality Weekly Reports (MMWR) on Recommendations of the Advisory Commitee on Immunization Practices (ACIP) related to vaccines and immunizations.
See also: All immunization schedules published in MMWR.
ACIP Vaccination Recommendations
Links to final CDC vaccination recommendations (published in MMWR) from Advisory Committee on Immunization Practices (ACIP).
Listed by date published
- Influenza vaccines (2012-13 season)
Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP — United States, 2012–13 Influenza Season
Source: MMWR; August 17, 2012 / 61(32);613-618 - Tdap for adults age 65 and older
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older, ACIP 2012
Source: MMWR; June 28, 2012 / 61(25);468-470 - Licensure of PCV13 for adults age 50 and older
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR; June 1, 2012 / 61(21);394-395 - New framework (GRADE) for development of evidence-based recommendations
New Framework (GRADE) for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices
Source: MMWR; May 11, 2012 / 61(18);327-327 - VariZIG for postexposure prophylaxis of varicella
FDA Approval of an Extended Period for Administering VariZIG for Postexposure Prophylaxis of Varicella
Source: MMWR; March 30, 2012 / 61(12);212-212 - Hepatitis B vaccine in adults with diabetes
Policy Note: Use of Hepatitis B Vaccine in Adults with Diabetes Mellitus
Source: MMWR; December 23, 2011 / 60(50);1709-11 - Use of HPV4 in males
Policy Note: Recommendations on Use of Quadrivalent HPV in Males - ACIP, 2011 Source: MMWR; December 23, 2011 / 60(50);1705-8
- Health care personnel immunization
Immunization of Health-Care Personnel: Recommendations of ACIP
Source: MMWR; November 25, 2011 / 60(RR07);1-45
- Herpes Zoster vaccine (Shingles)
Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 Through 59 Years
Source: MMWR; November 11, 2011 / 60(44);1528-1528 - Tdap and Td vaccines and pregnancy
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR; October 21, 2011 / 60(41);1424-1426 - Supplemental Meningococcal
Recommendation of the ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Source: MMWR; October 14, 2011 / 60(40);1391-1392 - Influenza vaccines (2011-12 season)
Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP, 2011
Source: MMWR; August 26, 2011 / 60(33);1128-1132 - Meningococcal conjugate vaccine
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease -- ACIP, 2011
Source: MMWR; August 5, 2011 / 60(40);1391-1392 - Booster dose of JE vaccine
Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine - ACIP, 2011
Source: MMWR; May 27, 2011 / 60(20);661-663 - JE vaccine for children
Update on Japanese Encephalitis Vaccine for Children -- United States, May 2011
Source: MMWR; May 27, 2011 / 60(20);664-665 - General Recommendations
General Recommendations on Immunization: Recommendations of the ACIP
Source: MMWR; January 28, 2011 / 60(RR02);1-60 - Meningococcal Conjugate vaccine
Updated Recommendations for Use of Meningococcal Conjugate Vaccines -- ACIP, 2010
Source: MMWR; January 28, 2011 / 60(03);72-76 - Influenza (Antiviral)
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza: Recommendations of ACIP
Source: MMWR; January 21, 2011 / 60(RR01);1-24 - Tdap vaccine
Updated Recommendations for the Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Accellular Pertussis (Tdap) Vaccine from the ACIP, 2010
Source: MMWR; January 14, 2011 / 60(01);13-15 - Pneumococcal (PCV13 and PPSV23) vaccine (infants & children)
Prevention of Pneumococcal Disease Among Infants and Children -- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
Source: MMWR; December 10, 2010 / 59(RR11);1-18 - Pneumococcal (PPSV23) vaccine (adults)
Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using PPSV23
Source: MMWR; September 3, 2010 / 59(34);1102-1106 - Afluria influenza vaccine (2010-2011 season)
Update: Recommendations of ACIP Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11
Source: MMWR; August 13, 2010 /59(31);989-992 - Influenza (and H1N1) vaccine
Prevention and Control of Influenza with Vaccines
Source: MMWR; August 6, 2010 /59(RR08);1-62
- Yellow Fever vaccine
Yellow Fever Vaccine: Recommendations of the ACIP
Source: MMWR; July 30, 2010 / 59(RR07);1-27
- Anthrax vaccine
Use of Anthrax Vaccine in the United States
Source: MMWR; July 23, 2010 / 59(RR06);1-30 - Human Papillomavirus (HPV2 and HPV4) vaccine
- Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the ACIP
Source: MMWR; May 28, 2010 / 59(20);626-629 - Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the ACIP
Source: MMWR; May 28, 2010 / 59(20);630-632
- Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the ACIP
- Measles, Mumps, Rubella and Varicella (MMRV) vaccine
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine Recommendations of the ACIP
Source: MMWR; May 7, 2010 / 59(RR03);1-12 - Influenza vaccine (Fluzone high-dose)
Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged ≥65 Years (Fluzone High-Dose) and Guidance for Use -- United States, 2010
Source: MMWR; April 30, 2010 / 59(16);485-486
- Rabies vaccine
Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies Recommendations of the ACIP
Source: MMWR; March 19, 2010 / 59(RR02);1-9 - Meningococcal Conjugate vaccine (Menveo)
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use -- ACIP, 2010
Source: MMWR; March 12, 2010 / 59(00);273 - 13-Valent Pneumococcal Conjugate vaccine (PCV13)
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children -- ACIP, 2010
Source: MMWR; March 12, 2010 / 59(09);258-261 - Japanese Encephalitis vaccines
Japanese Encephalitis Vaccines Recommendations of the ACIP
Source: MMWR; March 12, 2010 / 59(RR01);1-27 - Influenza A (H1N1) vaccine (2009)
Use of Influenza A (H1N1) 2009 Monovalent Vaccine: Recommendations of the ACIP, 2009
Source: MMWR; August 21, 2009 / 58(Early Release);1-8 - Influenza vaccines (2009)
Prevention and Control of Influenza: Recommendations of ACIP, 2009
Source: MMWR; July 31, 2009 / 58(RR08);1-52 - Rotavirus vaccine
Prevention of Rotavirus Gastroenteritis Among Infants and Children Recommendations of the ACIP
Source: MMWR; February 6, 2009 / 58(RR02);1-25 - Tdap vaccine and pregnancy
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants
Source: MMWR; May 30, 2008 / 57(04);1-47,51 - Herpes Zoster (Shingles) vaccine
Prevention of Herpes Zoster: Recommendations of the ACIP
Source: MMWR; May 15, 2008 / 57(Early Release);1-30 - Varicella vaccines
Prevention of Varicella: Recommendations of the ACIP
Source: MMWR; June 22, 2007 / 56(RR04);1-40 - HPV vaccine
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the ACIP
Source: MMWR; March 12, 2007 / 56(Early Release);1-24 - Tdap vaccine (adults)
Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Source: MMWR; December 15, 2006 / 55(RR17);1-33 -
Hepatitis B vaccine (adults)
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
Source: MMWR; December 8, 2006 / 55(RR16);1-25 - Rotavirus vaccine
Prevention of Rotavirus Gastroenteritis Among Infants and Children
Source: MMWR; August 11, 2006 / 55(RR12);1-13 - Hepatitis A vaccine (children)
Prevention of Hepatitis A Through Active or Passive Immunization
Source: MMWR; May 19, 2006 / 55(RR07);1-23 - Tdap vaccine (adolescents)
Preventing Tdap Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines
Source: MMWR; February 23, 2006 / 55(Early Release)1-34 - Hepatitis B vaccine
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
Source: MMWR; December 23, 2005 / 54(RR16);1-23
Links to Other CDC Recommendations
- A New Product (VariZIGÔ) for Postexposure Prophylaxis of Varicella Available Under an Investigational New Drug Application Expanded Access Protocol
Source: MMWR; February 24, 2006 / 55(Early Release)1-2 - Consult the American Academy of Pediatrics site for the current Status of Licensure and Recommendations for New Vaccines
This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.
File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)
Content last reviewed on July 18, 2012
Content Source: National Center for Immunization and Respiratory Diseases